Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qihang Yao

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ecotoxicology and Environmental Safety|February 4, 2026
6PPD-Q exposure promotes hepatocellular carcinoma progression and confers resistance to ferroptosisQihang Yao, Binbin Cao, Zihan Guo, et al.
Plos One|October 27, 2021
A weighted network analysis framework for the hourglass effect-And its application in the C. elegans connectomeIshaan Batta, Qihang Yao, Kaeser M Sabrin, et al.
Biomedical Engineering Online|May 5, 2018
Mobile GPU-based implementation of automatic analysis method for long-term ECGXiaomao Fan, Qihang Yao, Ye Li, et al.
IEEE Journal of Biomedical and Health Informatics|August 15, 2018
Multiscaled Fusion of Deep Convolutional Neural Networks for Screening Atrial Fibrillation From Single Lead Short ECG RecordingsXiaomao Fan, Qihang Yao, Yunpeng Cai, et al.
Cell & Bioscience|January 6, 2026
TGF-β1/SMAD signaling downregulates KLF4 expression via direct transcriptional suppression and FAT10-mediated proteasomal degradation in hepatocellular carcinomaZeping Chen, Senlin Zhao, Desheng Chen, et al.
Archives of Physical Medicine and Rehabilitation|March 7, 2025
Reliability and Validity of Instrumented Timed Up and Go Test in Typical Adults and Elderly: A Systematic ReviewJinyu Zhou, Qihang Yao, Ruihua Han, et al.
Journal of Clinical Epidemiology|February 23, 2026
Psychometric properties and reference values for the instrumented timed-up and go test in adultsJinyu Zhou, Qihang Yao, Ruihua Han, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2026
Conversion therapy using transarterial chemoembolization plus tislelizumab for unresectable hepatocellular carcinoma: effects on tumor necrosis and anti-tumor immune responseQihang Yao, Guangwen Chen, Yang Yu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ecotoxicology and Environmental Safety|February 4, 2026
6PPD-Q exposure promotes hepatocellular carcinoma progression and confers resistance to ferroptosisQihang Yao, Binbin Cao, Zihan Guo, et al.
Plos One|October 27, 2021
A weighted network analysis framework for the hourglass effect-And its application in the C. elegans connectomeIshaan Batta, Qihang Yao, Kaeser M Sabrin, et al.
Biomedical Engineering Online|May 5, 2018
Mobile GPU-based implementation of automatic analysis method for long-term ECGXiaomao Fan, Qihang Yao, Ye Li, et al.
IEEE Journal of Biomedical and Health Informatics|August 15, 2018
Multiscaled Fusion of Deep Convolutional Neural Networks for Screening Atrial Fibrillation From Single Lead Short ECG RecordingsXiaomao Fan, Qihang Yao, Yunpeng Cai, et al.
Cell & Bioscience|January 6, 2026
TGF-β1/SMAD signaling downregulates KLF4 expression via direct transcriptional suppression and FAT10-mediated proteasomal degradation in hepatocellular carcinomaZeping Chen, Senlin Zhao, Desheng Chen, et al.
Archives of Physical Medicine and Rehabilitation|March 7, 2025
Reliability and Validity of Instrumented Timed Up and Go Test in Typical Adults and Elderly: A Systematic ReviewJinyu Zhou, Qihang Yao, Ruihua Han, et al.
Journal of Clinical Epidemiology|February 23, 2026
Psychometric properties and reference values for the instrumented timed-up and go test in adultsJinyu Zhou, Qihang Yao, Ruihua Han, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2026
Conversion therapy using transarterial chemoembolization plus tislelizumab for unresectable hepatocellular carcinoma: effects on tumor necrosis and anti-tumor immune responseQihang Yao, Guangwen Chen, Yang Yu, et al.
Pageof 1